Profound Medical (PROF) Cost of Revenue (2024 - 2026)

Profound Medical's Cost of Revenue history runs 3 years deep, the most recent figure standing at $1.5 million for Q1 2026.

• On a quarterly basis, Cost of Revenue rose 95.96% year-over-year to $1.5 million in Q1 2026; TTM through Mar 2026 was $5.4 million, a 41.79% increase from a year earlier, with the FY2025 full-year figure at $4.7 million, up 29.15% from the prior year.
• Cost of Revenue fell to $1.5 million in Q1 2026 per PROF's latest filing, from $2.0 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $2.0 million in Q4 2025 and bottomed at $573000.0 in Q1 2024.
• The 3-year median for Cost of Revenue is $1.0 million (2024), against an average of $1.1 million.
• Across the five-year window, Cost of Revenue retreated 26.97% in 2025 and surged 95.96% in 2026, its largest moves.
• Year by year, Cost of Revenue stood at $1.2 million in 2024, then jumped by 63.59% to $2.0 million in 2025, then fell by 24.22% to $1.5 million in 2026.
• Per Business Quant, the three latest PROF Cost of Revenue figures stand at $1.5 million (Q1 2026), $2.0 million (Q4 2025), and $1.4 million (Q3 2025).